Perbedaan Japfa Comfeed Indonesia Tbk. dan Charlie Hospital Semarang Tbk.: Japfa Comfeed Indonesia Tbk. diperdagangkan di Rp2.030 (kapitalisasi pasar 23,8 T, volume 24 jam 8,44 jt), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 678,4 M, volume 24 jam 25,57 jt). Perbedaan utamanya: Japfa Comfeed Indonesia Tbk. jauh lebih besar — sekitar 35,1× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Charlie Hospital Semarang Tbk. lebih aktif diperdagangkan (25,57 jt vs 8,44 jt). Mana yang lebih baik tergantung tujuan investasimu.
| JPFA | RSCH | |
|---|---|---|
Kapitalisasi Pasar | 23,8 T | 678,4 M |
Volume | 8,44 jt | 25,57 jt |
Lot | 84,36 rb | 255,67 rb |
Perputaran | 17,08 M | 6,57 M |
Harga Rata-rata | 2.024,41 | 256,8 |
Nilai Transaksi | 17,08 M | 6,57 M |
Harga Ekuilibrium Indikatif | 2.030 | 258 |
Volume Ekuilibrium Indikatif | 3,58 rb | 110 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Japfa Comfeed Indonesia Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 based on Notarial Deed No. 59 dated January 18, 1971 of Djojo Muljadi, S.H., public notary, as amended by Notarial Deed No. 60 dated Februari 15, 1972, of the same notary. Japfa is currently the second largest animal feed producer in Indonesia with an estimated market share of around 35% in the domestic poultry feed market. The company was originally involved in the production of copra extraction pellets
Selengkapnya di halaman JPFA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →